These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 29495204

  • 1. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
    Duan LX, Li XL, Hu PW, Luo R, Luo X, Chen YY.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb 10; 39(2):194-198. PubMed ID: 29495204
    [Abstract] [Full Text] [Related]

  • 2. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
    Bawor M, Dennis BB, Tan C, Pare G, Varenbut M, Daiter J, Plater C, Worster A, Marsh DC, Steiner M, Anglin R, Desai D, Thabane L, Samaan Z.
    Addict Sci Clin Pract; 2015 Oct 06; 10():19. PubMed ID: 26437921
    [Abstract] [Full Text] [Related]

  • 3. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
    Doehring A, Hentig Nv, Graff J, Salamat S, Schmidt M, Geisslinger G, Harder S, Lötsch J.
    Pharmacogenet Genomics; 2009 Jun 06; 19(6):407-14. PubMed ID: 19373123
    [Abstract] [Full Text] [Related]

  • 4. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F, Gratacòs M, Escaramís G, De Cid R, Martín-Santos R, Fernández-Espejo E, Estivill X, Torrens M.
    Mol Diagn Ther; 2010 Jun 01; 14(3):171-8. PubMed ID: 20560679
    [Abstract] [Full Text] [Related]

  • 5. Association of COMT Gene Polymorphisms with Response to Methadone Maintenance Treatment Among Chinese Opioid-Dependent Patients.
    Duan L, Li X, Yan J, Chen Y, Luo R, Zhang Q, Feng X, Li X.
    Genet Test Mol Biomarkers; 2020 Jun 01; 24(6):364-369. PubMed ID: 32407152
    [Abstract] [Full Text] [Related]

  • 6. Patient perception of methadone dose adequacy in methadone maintenance treatment: The role of perceived participation in dosage decisions.
    Trujols J, González-Saiz F, Manresa MJ, Alcaraz S, Batlle F, Duran-Sindreu S, Pérez de Los Cobos J.
    Patient Educ Couns; 2017 May 01; 100(5):981-986. PubMed ID: 27988071
    [Abstract] [Full Text] [Related]

  • 7. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО, Krupitsky ЕМ, Blokhina ЕА, Verbitskaya ЕV, Brodyansky VМ, Alekseeva NP, Bushara NМ, Yaroslavtseva ТS, Palatkin VY, Masalov DV, Burakov АМ, Romanova ТN, Sulimov GY, Grinenko AY, Kosten Т, Nielsen D, Zvartau EE.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016 May 01; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S, Besson J, Croquette-Krokar M, Hämmig R, Gothuey I, Monnat M, Déglon JJ, Preisig M, Eap CB.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct 01; 32(7):1722-7. PubMed ID: 18687376
    [Abstract] [Full Text] [Related]

  • 10. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.
    Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA.
    Pharmacogenet Genomics; 2013 Jul 01; 23(7):333-40. PubMed ID: 23635803
    [Abstract] [Full Text] [Related]

  • 11. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
    Hung CC, Chiou MH, Huang BH, Hsieh YW, Hsieh TJ, Huang CL, Lane HY.
    Pharmacogenomics; 2011 Nov 01; 12(11):1525-33. PubMed ID: 21902500
    [Abstract] [Full Text] [Related]

  • 12. ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy.
    Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R.
    Nurs Res; 2017 Nov 01; 66(2):134-144. PubMed ID: 28252574
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
    Albonaim A, Fazel H, Sharafshah A, Omarmeli V, Rezaei S, Ajamian F, Keshavarz P.
    J Addict Dis; 2017 Nov 01; 36(4):227-235. PubMed ID: 28786760
    [Abstract] [Full Text] [Related]

  • 15. Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments.
    Barratt DT, Coller JK, Somogyi AA.
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun 05; 141B(4):323-31. PubMed ID: 16583408
    [Abstract] [Full Text] [Related]

  • 16. APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment.
    Liu CC, Fang CP, Liu TH, Kuo HW, Liu SC, Wang SC, Chen ACH, Liu YL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr 20; 83():92-98. PubMed ID: 29330135
    [Abstract] [Full Text] [Related]

  • 17. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.
    Levran O, Peles E, Randesi M, Shu X, Ott J, Shen PH, Adelson M, Kreek MJ.
    Pharmacogenomics; 2013 May 20; 14(7):755-68. PubMed ID: 23651024
    [Abstract] [Full Text] [Related]

  • 18. The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment.
    Lawford BR, Young RM, Noble EP, Sargent J, Rowell J, Shadforth S, Zhang X, Ritchie T.
    Am J Med Genet; 2000 Oct 09; 96(5):592-8. PubMed ID: 11054765
    [Abstract] [Full Text] [Related]

  • 19. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
    Oueslati B, Moula O, Ghachem R.
    Pharmacogenomics; 2018 Jun 01; 19(8):741-747. PubMed ID: 29785888
    [Abstract] [Full Text] [Related]

  • 20. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies.
    Chen D, Liu F, Shang Q, Song X, Miao X, Wang Z.
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep 01; 156B(6):661-70. PubMed ID: 21714067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.